Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

But the biggest reason Novo isn't overly concerned is because Medicare is not its largest market in the US. Until the start of 2025, only Ozempic and Rybelsus for diabetes were co ...

Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

Investigators have recovered the cockpit voice recorder of a medical transport jet that crashed Jan. 31 in Philadelphia, ...

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

"We have already invited a lot of politicians and different stakeholders to a party ... Some of Norway's EV incentives ...

play area and outdoor cooking area for Nisqually Tribe events, according to previous reporting from The News Tribune and The Olympian. It would be built near the existing day-use parking lot. The ...

Novo Nordisk shares rose sharply Friday after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their bodyweight in a clinical trial. Shares were 10 ...

Finally, some good news for Novo Nordisk (NYSE: NVO) shareholders! Twice in the past two months, the Danish manufacturer of GLP-1 drugs for weight loss and diabetes treatment has reported clinical ...

Tamale vendors, a hearty group used to braving all kinds of weather, weren’t lined up on the sidewalks. The hardware store parking lots, where day laborers search for work, also were largely empty.